FEC chemotherapy. The drugs that are used. How treatment is given
|
|
|
- Janice Sherman
- 10 years ago
- Views:
Transcription
1 Macmillan and Cancerbackup have merged. Together we provide free, high quality information for all. FEC chemotherapy This fact sheet is about a chemotherapy treatment for breast cancer called FEC. It describes the drugs used, how they are given and some of the possible side effects. It should ideally be read with our general information about chemotherapy and breast cancer. You will see your doctor regularly while you have this treatment so they can monitor the effects of the chemotherapy. This fact sheet should help you to discuss any queries about your treatment and its side effects with your doctor, chemotherapy nurse or pharmacist. If you d like to discuss this information with our cancer support specialists, call the Macmillan Support Line free on , Monday Friday, 9am 8pm. If you re hard of hearing you can use textphone , or Text Relay. For non English speakers, interpreters are available. Alternatively, visit macmillan.org.uk Includes the following information The drugs that are used How treatment is given How often treatment is given Possible side effects Less common side effects Additional information Things to remember about cyclophosphamide tablets Related Macmillan information The drugs that are used FEC is named after the initials of the chemotherapy drugs used, which are: fluorouracil, which is also known as 5FU epirubicin cyclophosphamide. How treatment is given FEC treatment can usually be given to you as a day patient. Before you start treatment, you will need to have a blood test either on the same day or a day or two beforehand. You will also be seen by a doctor, specialist nurse or pharmacist. If the results of your blood test are normal, the pharmacy will prepare your chemotherapy drugs. All of this may take a couple of hours. The nurse will then insert a thin, flexible tube (cannula) into a vein in your hand or Page 1 of 6 Macmillan fact sheet 2011: FEC chemotherapy
2 arm. You may find this uncomfortable or a little painful but it shouldn't take long. Some people have their chemotherapy given through a thin plastic tube, which is inserted under the skin into a vein near the collarbone (central line), or passed through a vein in the crook of their arm (PICC line). Your doctor or nurse will explain more about this to you. You will be given some anti-sickness (anti-emetic) drugs either as tablets, or more usually by injection through the cannula, which is often connected to a drip (infusion). The chemotherapy drugs are then given separately: epirubicin (a red fluid) is given as an injection along with a drip (infusion) of salt water (saline) into your cannula or line 5FU (a colourless fluid) is given in the same way cyclophosphamide (a colourless fluid) can be given either as an infusion or as an injection alongside a drip of saline. The cyclophosphamide can also be given as a course of (pink or white) tablets over two weeks see Schedule B. The chemotherapy will usually take about an hour, but may take longer. Although the epirubicin is often given first, the order in which the drugs are given won't alter their effectiveness. If you are having your treatment as a day patient you can then go home, and the cannula will be removed before you go. If you have a central or PICC line it will usually stay in place, ready for the next cycle of your chemotherapy. You will be shown how to look after the line. You will be given a supply of anti-sickness drugs to take home with you. It is important to take these regularly as directed even if you aren't feeling sick. This is because some anti-sickness drugs are much better at preventing sickness than stopping it once it starts. How often treatment is given Your doctor may use the word 'regimen' (eg FEC regimen) when talking about your chemotherapy. This means the whole plan or schedule of your particular chemotherapy treatment. There are two different schedules for giving FEC. Ask your doctor or nurse to explain if you aren't sure which one you are having. Schedule A On the first day of your treatment you will be given all three drugs (5FU, epirubicin and cyclophosphamide) by infusion and injections into the cannula or line. After this you will have a rest period with no chemotherapy for the next three weeks. This completes a cycle of your treatment. After the rest period the same drugs will be given to you again, beginning the next cycle of your treatment. Usually 4 6 cycles are given over a period of 3 4 months. This makes up a course of treatment. Schedule B On the first day of your treatment you will be given 5FU and epirubicin. You will also begin a two-week course of cyclophosphamide tablets. One week later (on day 8) you will be given the 5FU and epirubicin again. When you have finished taking your cyclophosphamide tablets you will have a rest period with no chemotherapy for the next two weeks. This completes a cycle of your chemotherapy. You will start the next cycle of your treatment after the rest period, which will be four weeks after your first injection. Usually 4 6 cycles are usually given over a period of 4 6 months. This makes up a course of treatment. Possible side effects Each person s reaction to chemotherapy is different. Some people have very few side effects while others may have more. The side effects described here won't affect everyone who is having FEC chemotherapy. Page 2 of 6 Macmillan fact sheet 2011: FEC chemotherapy
3 We have outlined the most common side effects but haven't included those that are rare and therefore unlikely to affect you. If you notice any effects which aren't listed here, discuss them with your doctor, chemotherapy nurse or pharmacist. Lowered resistance to infection (neutropenia) FEC can reduce the number of white blood cells produced by the bone marrow, making you more prone to infection. This effect can begin seven days after treatment, with your resistance to infection usually reaching its lowest point days after chemotherapy. The number of your white blood cells will then increase steadily and usually return to normal before your next cycle of chemotherapy is due. Contact your doctor or the hospital straight away if: your temperature goes above 38 C (100.4 F) you suddenly feel unwell, even with a normal temperature. You will have a blood test before having more chemotherapy to make sure that the number of white blood cells has recovered. Occasionally, it may be necessary to delay treatment if the number of blood cells (blood count) is still low. Bruising or bleeding FEC can reduce the production of platelets, which help the blood to clot and stop bleeding. Tell your doctor if you have any unexplained bruising or bleeding, such as nosebleeds, bleeding gums, blood spots or rashes on the skin. drugs, which may be more effective. Some anti-sickness drugs may cause constipation. Let your doctor or nurse know if this is a problem. Tiredness Many people feel extremely tired (fatigued) during chemotherapy, particularly towards the end of treatment. This is a very common side effect and it's important to try to get as much rest as you need. Hair loss This usually starts 3 4 weeks after the first course of treatment. Hair usually falls out completely. You may also experience thinning and loss of eyelashes, eyebrows and other body hair. This is temporary and your hair will start grow back once treatment has finished. Your nurse can give you advice about coping with hair loss. Scalp cooling is a method of reducing hair loss that may be helpful for some people. You can ask your doctor or nurse if it's available at your hospital. Sore mouth and ulcers Your mouth may become sore or dry, or you may notice small ulcers during this treatment. Drinking plenty of fluids, and cleaning your teeth regularly with a soft toothbrush, can help to reduce the risk of this happening. Tell your nurse or doctor if you have any of these problems, as they can prescribe mouthwashes and medicine to prevent or clear any mouth infections. Taste changes You may notice that food tastes different. Normal taste usually comes back after treatment finishes. Anaemia (low number of red blood cells) You may become anaemic while having treatment with FEC. This may make you feel tired and breathless. Tell your doctor or nurse if you have these symptoms. Feeling sick (nausea) and being sick (vomiting) Your doctor can prescribe very effective anti-sickness (anti-emetic) drugs to prevent or reduce this. If the sickness isn't controlled, or if it continues, tell your doctor. They can prescribe other anti-sickness Irritation of the bladder Cyclophosphamide may irritate your bladder. It is useful to drink plenty of fluid (up to about two litres) on the day following chemotherapy to prevent this. Tell your doctor if you notice any blood in your urine. Epirubicin is red and due to this your urine may become a pink/red colour. This is normal and may last up to 24 hours after treatment. Page 3 of 6 Macmillan fact sheet 2011: FEC chemotherapy
4 Diarrhoea If you have diarrhoea it can usually be controlled easily with medicine. Let your doctor know if it is severe or if it continues. Try to drink as much as 2 3 litres of liquid a day to replace the fluid you are losing. Gritty eyes and blurred vision If this happens, let your doctor know. They can prescribe soothing eye drops. Less common side effects Skin changes You may develop an itchy rash. Your doctor can prescribe medicine to help with this. Sometimes areas which have previously been treated with radiotherapy may become red and sore. Let your doctor know if this happens. The skin over the vein used for the injection may become discoloured. Also, your skin may darken. This will slowly return to normal a few months after the treatment finishes. During the treatment, and for several months afterwards, you will be more sensitive to the sun and your skin may burn more easily. You can still go out in the sun, but should wear a suncream with a high sun protection factor (SPF) and cover up with clothing and a hat. Nail changes Your nails may become darker and white lines may appear on them. These changes usually grow out over a few months once treatment ends. Your liver may be temporarily affected The treatment can cause changes in the way that your liver works, although your liver will return to normal when the treatment finishes. This is very unlikely to cause you any harm, but your doctor will monitor you carefully. They will take samples of your blood from time to time to check your liver is working properly. Changes in the way your heart works This is very rare with usual doses of these drugs, but may occasionally happen when high doses are used. Tests to see how well your heart is working may be carried out before you start treatment. Always let your doctor or nurse know about any side effects you are having. There are usually ways in which they can be controlled or improved. Additional information Leakage into the tissue around the vein If this happens while epirubicin is being given, the tissue in that area can be damaged. If you notice any stinging or burning around the vein while the drug is being given, tell your doctor or nurse immediately. Risk of blood clots Cancer can increase your risk of developing a blood clot (thrombosis), and having chemotherapy may increase this risk further. A blood clot may cause symptoms such as pain, redness and swelling in a leg, or breathlessness and chest pain. Blood clots can be very serious, so it is important to tell your doctor straight away if you have any of these symptoms. Most clots can be treated with drugs that thin the blood. Your doctor or nurse can give you more information. Other medicines Some medicines, including those you can buy in a shop or chemist, can be harmful to take when you are having chemotherapy. Tell your doctor about any medicines you are taking, including over-the-counter drugs, complementary therapies and herbal drugs. Fertility Your ability to conceive a child may be affected by this treatment. It's important to discuss fertility with your doctor before starting treatment. Contraception It's not advisable to become pregnant or father a child while having this treatment, as it may harm the developing baby. It is important to use effective contraception while taking these drugs, and for at least a few months afterwards. You can discuss this with your doctor. Page 4 of 6 Macmillan fact sheet 2011: FEC chemotherapy
5 Loss of periods Due to the effect of chemotherapy on the ovaries, you may find that your periods become irregular and may eventually stop. In younger women this may be temporary but if you are closer to your menopause it may be permanent. This will result in menopausal symptoms such as hot flushes, sweats and vaginal dryness. Things to remember about cyclophosphamide tablets It is important to take your tablets at the right times, as directed by your doctor. Always tell any doctors treating you for any non-cancerous conditions that you're taking a course of steroid tablets that shouldn't be stopped without the advice of your cancer specialist. Keep the tablets in the original packaging and store them at room temperature, away from heat and direct sunlight. Keep the cyclophosphamide in a safe place, out of the reach of children. If your doctor decides to stop the treatment, return any remaining tablets to the pharmacist. Do not flush them down the toilet or throw them away. If you are sick just after taking the tablet, let your doctor know. You may need to take another dose. Don't take another tablet without telling your doctor first. If you forget to take a tablet don't take a double dose. Let your doctor know and keep to your regular dose schedule. Related Macmillan information Avoiding infection when you have reduced immunity Breast cancer and menopausal symptoms Cancer treatment and fertility Central lines (skin-tunnelled venous catheters) Controlling nausea and vomiting Coping with fatigue Coping with hair loss Diet and cancer Mouth care during chemotherapy PICC lines (peripherally inserted central catheters) Scalp cooling Understanding breast cancer Understanding breast cancer in men Understanding chemotherapy For copies of this related information call free on , or see it online at macmillan.org.uk This fact sheet has been written, revised and edited by Macmillan Cancer Support s information development nurses and editorial team. It has been approved by our medical editor, Dr Terry Priestman, Consultant Clinical Oncologist. With thanks to Christine Clarke and the people affected by cancer who reviewed this edition. This fact sheet has been compiled using information from a number of reliable sources, including: Sweetman, et al. Martindale: The Complete Drug Reference. 36 th edition Pharmaceutical Press. British National Formulary. 58 th edition British Medical Association and Royal Pharmaceutical Society of Great Britain. Perry MC. The Chemotherapy Source Book. 4 th edition Lippincott, Williams and Wilkins. This fact sheet was revised in The next edition will be available in Page 5 of 6 Macmillan fact sheet 2011: FEC chemotherapy
6 We make every effort to ensure that the information we provide is accurate but it should not be relied upon to reflect the current state of medical research, which is constantly changing. If you are concerned about your health, you should consult your doctor. Macmillan cannot accept liability for any loss or damage resulting from any inaccuracy in this information or third party information such as information on websites to which we link. Macmillan Cancer Support Registered charity in England and Wales (261017), Scotland (SC039907) and the Isle of Man (604). Registered office 89 Albert Embankment, London, SE1 7UQ. MAC11748_11 Page 6 of 6 Macmillan fact sheet 2011: FEC chemotherapy
Chemotherapy for lung cancer
This information is an extract from the booklet Understanding lung cancer. You may find the full booklet helpful. We can send you a free copy see page 8. Contents Chemoradiation Small cell lung cancer
Chemotherapy for non-small cell lung cancer
Chemotherapy for non-small cell lung cancer This information is an extract from the booklet Understanding lung cancer. You may find the full booklet helpful. We can send you a free copy see page 3. Contents
Chemotherapy for head and neck cancers
Chemotherapy for head and neck cancers This information is from the booklet Understanding head and neck cancers. You may find the full booklet helpful. We can send you a free copy see page 7. Contents
Other treatments for chronic myeloid leukaemia
Other treatments for chronic myeloid leukaemia This information is an extract from the booklet Understanding chronic myeloid leukaemia. You may find the full booklet helpful. We can send you a copy free
Treatment for pleural mesothelioma
Treatment for pleural mesothelioma This information is an extract from the booklet Understanding mesothelioma. You may find the full booklet helpful. We can send you a free copy see page 9. Contents Treatment
FEC chemotherapy Factsheet
FEC chemotherapy Factsheet This factsheet explains what the chemotherapy combination FEC is, when it may be prescribed, how it works and what side effects may occur. 2 What is FEC? Visit www.breastcancercare.org.uk
Docetaxel (Taxotere) This booklet explains what docetaxel is, when it may be prescribed, how it works and what side effects may occur.
Docetaxel (Taxotere) This booklet explains what docetaxel is, when it may be prescribed, how it works and what side effects may occur. Treatment Lorem ipsum and dolore side effects estes 2 Call our Helpline
Chemotherapy for acute myeloid leukaemia
Chemotherapy for acute myeloid leukaemia This information is an extract from the booklet Understanding acute myeloid leukaemia. You may find the full booklet helpful. We can send you a free copy see page
Vincristine by short infusion Doxorubicin by injection Cyclophosphamide by injection Rituximab by an infusion over between 60 minutes to a few hours
R-CHOP R-CHOP This leaflet is offered as a guide to you and your family. The possible benefits of treatment vary; for some people chemotherapy may reduce the risk of the cancer coming back, for others
Patient identifier/label: Page 1 of 6 PATIENT AGREEMENT TO SYSTEMIC THERAPY: CONSENT FORM FEC-T. Patient s first names. Date of birth.
Patient identifier/label: Page 1 of 6 PATIENT AGREEMENT TO SYSTEMIC THERAPY: CONSENT FORM FEC-T Patient s surname/family name Patient s first names Date of birth Hospital Name: Guy s Hospital St. Thomas
Temozolomide (oral) with concurrent radiotherapy to the brain
Temozolomide (oral) with concurrent radiotherapy to the brain Temozolomide (oral) with concurrent radiotherapy to the brain This leaflet is offered as a guide to you and your family. You will find it useful
Radiotherapy for breast cancer
Radiotherapy for breast cancer This information is an extract from the booklet Understanding breast cancer. You may find the full booklet helpful. We can send you a copy free see page 6. Contents Radiotherapy
Radioactive iodine treatment for thyroid cancer
Radioactive iodine treatment for thyroid cancer This information is an extract from the booklet, Understanding thyroid cancer. You may find the full booklet helpful. We can send you a copy free see page
Chemotherapy. What is chemotherapy? How does it work? What is cancer? How will I be given chemotherapy? Cannula
INFORMATION SHEET This information sheet has been written to help you understand more about chemotherapy. The sheet discusses the support and information your doctors, nurses and the Cancer Society can
Radiotherapy for vulval cancer
This information is an extract from the booklet Understanding cancer of the vulva. You may find the full booklet helpful. We can send you a copy free see page 6. Contents External radiotherapy Internal
CHOP Chemotherapy Regimen for Lymphoma Information for Patients
CHOP Chemotherapy Regimen for Lymphoma Information for Patients The Regimen Contains: C: Cytoxan (cyclophosphamide) H: Adriamycin (hydroxy doxorubicin) O: vincristine (Oncovin ) P: Prednisone How Is This
VAD Chemotherapy Regimen for Multiple Myeloma Information for Patients
VAD Chemotherapy Regimen for Multiple Myeloma Information for Patients The Regimen contains: V = vincristine (Oncovin ) A = Adriamycin (doxorubicin) D = Decadron (dexamethasone) How Is This Regimen Given?
For the Patient: Paclitaxel injection Other names: TAXOL
For the Patient: Paclitaxel injection Other names: TAXOL Paclitaxel (pak'' li tax' el) is a drug that is used to treat many types of cancer. It is a clear liquid that is injected into a vein. Tell your
Graft-versus-host disease (GvHD)
Graft-versus-host disease (GvHD) This information is an extract from the booklet Understanding donor stem cell (allogeneic) transplants. You may find the full booklet helpful. We can send you a free copy
Understanding Cytotoxic Chemotherapy
Understanding Cytotoxic Chemotherapy Introduction Chemotherapy is part of your continuing treatment. This booklet has been compiled in an effort to help you understand cytotoxic chemotherapy. It is your
Breast Cancer. Breast Cancer Page 1
Breast Cancer Summary Breast cancers which are detected early are curable by local treatments. The initial surgery will give the most information about the cancer; such as size or whether the glands (or
Chemotherapy for pancreatic
Chemotherapy for pancreatic cancer 1 Chemotherapy for pancreatic cancer This information is from the booklet Understanding pancreatic cancer. You may find the full booklet helpful. We can send you a free
CVP Chemotherapy Regimen for Lymphoma Information for Patients
CVP Chemotherapy Regimen for Lymphoma Information for Patients The Regimen Contains: C: Cyclophosphamide (Cytoxan ) V: Vincristine (Oncovin ) P: Prednisone How Is This Regimen Given? CVP is given every
CMF: Cyclophosphamide, Methotrexate and Fluorouracil
PATIENT EDUCATION patienteducation.osumc.edu CMF: Cyclophosphamide, Methotrexate and Fluorouracil What is CMF? This is the short name for the drugs used for this chemotherapy treatment. The three drugs
For the Patient: BRAJFECD Other Names: Adjuvant Therapy for Breast Cancer Using Fluorouracil, Epirubicin and Cyclophosphamide and Docetaxel
For the Patient: BRAJFECD Other Names: Adjuvant Therapy for Breast Cancer Using Fluorouracil, Epirubicin and Cyclophosphamide and Docetaxel BR = BReast AJ = AdJuvant F = Fluorouracil E = Epirubicin C =
X-Plain Chemotherapy for Breast Cancer - Adriamycin, Cytoxan, and Tamoxifen Reference Summary
X-Plain Chemotherapy for Breast Cancer - Adriamycin, Cytoxan, and Tamoxifen Reference Summary Introduction Breast cancer is a common condition that affects one out of every 11 women. Your doctor has recommended
Contents. Overview. Removing the womb (hysterectomy) Overview
This information is an extract from the booklet Understanding womb (endometrial) cancer. You may find the full booklet helpful. We can send you a free copy see page 9. Overview Contents Overview Removing
How To Take A Strong Opioid Painkiller
Using strong painkillers for cancer pain This information is an extract from the booklet Controlling cancer pain. You may find the full booklet helpful. We can send you a copy free see page 8. Contents
Treating Mesothelioma - A Quick Guide
Treating Mesothelioma - A Quick Guide Contents This is a brief summary of the information on Treating mesothelioma from CancerHelp UK. You will find more detailed information on the website. In this information
Physical therapies. Massage
This information is an extract from the booklet, Understanding complementary therapies. You may find the full booklet helpful. We can send you a copy free see page 6. This information discusses eight physical
UW MEDICINE PATIENT EDUCATION. Xofigo Therapy. For metastatic prostate cancer. What is Xofigo? How does it work?
UW MEDICINE PATIENT EDUCATION Xofigo Therapy For metastatic prostate cancer This handout explains how the drug Xofigo is used to treat metastatic prostate cancer. What is Xofigo? Xofigo is a radioactive
AC: Doxorubicin and Cyclophosphamide
PATIENT EDUCATION patienteducation.osumc.edu What is AC? It is the short name for the drugs used for this chemotherapy treatment. The two drugs you will receive during this treatment are Doxorubicin (Adriamycin
FOLFOX Chemotherapy. This handout provides information about FOLFOX chemotherapy. It is sometimes called as FLOX chemotherapy.
FOLFOX Chemotherapy This handout provides information about FOLFOX chemotherapy. It is sometimes called as FLOX chemotherapy. What is chemotherapy? Chemotherapy is a method of treating cancer by using
Ovarian cancer. Patient information from the BMJ Group. What is ovarian cancer? What are the symptoms?
Patient information from the BMJ Group Ovarian cancer Ovarian cancer is a serious disease. If it s diagnosed at an early stage, ovarian cancer can usually be cured. But even cancers that are more advanced
TC Chemotherapy Regimen (Docetaxel + Cyclophosphamide)
TC Chemotherapy Regimen (Docetaxel + Cyclophosphamide) TC is a regimen or treatment plan that includes a combination of chemotherapy drugs that your doctor prescribed for the treatment of your cancer.
AC Chemotherapy Regimen (Doxorubicin + Cyclophosphamide)
AC Chemotherapy Regimen (Doxorubicin + Cyclophosphamide) AC is a regimen or treatment plan that includes a combination of chemotherapy drugs that your doctor prescribed for the treatment of your cancer.
For the Patient: CHOP-R Other names: LYCHOP-R
1 For the Patient: CHOP-R Other names: LYCHOP-R C H O P R Cyclophosphamide Doxorubicin (also known as ADRIAMYCIN ) Vincristine (also known as ONCOVIN ) Prednisone (taken by mouth) Rituximab (also known
Deciding whether to become a parent
Deciding whether to become a parent This information is an extract from the booklet, Relationships, sex and fertility for young people affected by cancer. You may find the full booklet helpful. We can
Radiotherapy to the chest wall
Oxford University Hospitals NHS Trust The Radiotherapy Department Radiotherapy to the chest wall Information for patients Introduction This leaflet is for people who have had surgery for breast cancer
Radiotherapy for a mesothelioma
Oxford University Hospitals NHS Trust The Radiotherapy Department Radiotherapy for a mesothelioma Information for patients Introduction This leaflet is for people who have been recommended treatment with
For the Patient: GDP Other names: LYGDP
1 For the Patient: GDP Other names: LYGDP G D P Gemcitabine Dexamethasone (taken by mouth) CISPlatin Uses: GDP is a drug treatment given for Non-Hodgkins and Hodgkin Lymphoma with the expectation of destroying
Rivaroxaban to prevent blood clots for patients who have a lower limb plaster cast. Information for patients Pharmacy
Rivaroxaban to prevent blood clots for patients who have a lower limb plaster cast Information for patients Pharmacy Your doctor has prescribed a tablet called rivaroxaban. This leaflet tells you about
Mouth care during chemotherapy
Some people having chemotherapy treatment find that their mouth gets sore. This information gives some tips about how you can look after your mouth before and during your chemotherapy treatment. In this
Massage therapy and energy-based therapies
Massage therapy and energy-based therapies This information is an extract from the booklet Complementary therapies and cancer. You may find the full booklet helpful. We can send you a copy free see page
TC: Docetaxel and Cyclophosphamide
PATIENT EDUCATION patienteducation.osumc.edu What is TC? It is the short name for the drugs used for this chemotherapy treatment. The two drugs you will receive during this treatment are Docetaxel (Taxotere
Surgery for breast cancer in men
Surgery for breast cancer in men This information is an extract from the booklet Understanding breast cancer in men. You may find the full booklet helpful. We can send you a free copy see page 9. Contents
Surgery and cancer of the pancreas
Surgery and cancer of the pancreas This information is an extract from the booklet Understanding cancer of the pancreas. You may find the full booklet helpful. We can send you a free copy see page 8. Introduction
Mitoxantrone. For multiple sclerosis. InfoNEURO INFORMATION FOR PATIENTS. Montreal Neurological Hospital
i InfoNEURO Montreal Neurological Hospital INFORMATION FOR PATIENTS Mitoxantrone For multiple sclerosis Centre universitaire de santé McGill McGill University Health Centre Collaborators: D. Lowden Clinical
ORAL ANTICOAGULANTS RIVAROXABAN (XARELTO) FOR PULMONARY EMBOLISM (PE)
ORAL ANTICOAGULANTS RIVAROXABAN (XARELTO) FOR PULMONARY EMBOLISM (PE) Information Leaflet Your Health. Our Priority. Page 2 of 6 What Are Anticoagulants And What Do They Do? This information leaflet has
ORAL ANTICOAGULANTS - RIVAROXABAN (XARELTO) FOR DEEP VEIN THROMBOSIS (DVT)
ORAL ANTICOAGULANTS - RIVAROXABAN (XARELTO) FOR DEEP VEIN THROMBOSIS (DVT) Information Leaflet Your Health. Our Priority. Page 2 of 6 What Are Anticoagulants And What Do They Do? This information leaflet
PERIPHERAL STEM CELL TRANSPLANT INTRODUCTION
PERIPHERAL STEM CELL TRANSPLANT INTRODUCTION This booklet was designed to help you and the important people in your life understand the treatment of high dose chemotherapy with stem cell support: a procedure
Chemotherapy What It Is, How It Helps
Chemotherapy What It Is, How It Helps What s in this guide If your doctor has told you that you have cancer, you may have a lot of questions. Can I be cured? What kinds of treatment would be best for me?
Controlling symptoms of mesothelioma
Controlling symptoms of mesothelioma This information is an extract from the booklet Understanding mesothelioma. You may find the full booklet helpful. We can send you a free copy see page 9. Contents
How To Deal With The Side Effects Of Radiotherapy
Radiotherapy to the Bowel (Colo-Rectal Tumours) Information for patients Northern Centre for Cancer Care Freeman Hospital Introduction Your oncologist has advised you to have a course of radiotherapy to
Menopause: should I take HRT?
Patient information from the BMJ Group Menopause: should I take HRT? The menopause is when your periods stop for good. It isn't an illness. It's a normal part of every woman's life. But sometimes it causes
After pelvic radiotherapy
After pelvic radiotherapy in women 1 After pelvic radiotherapy in women This information is from the booklet Pelvic radiotherapy in women managing side effects during treatment. You may find the full booklet
Patient information. Goserelin Zoladex Breast Services Directorate PIF 1005 V3
Patient information Goserelin Zoladex Breast Services Directorate PIF 1005 V3 What is Goserelin? Goserelin is a tried and tested drug used to treat breast cancer. It can be used alone or given with other
Treatment of colon cancer
Treatment of colon cancer This information is an extract from the booklet, Understanding colon cancer. You may find the full booklet helpful. We can send you a copy free see page 5. Contents How treatment
For the Patient: Protocol LUAJNP Other names: Adjuvant Treatment of Non-Small Cell Lung Cancer with Cisplatin and Vinorelbine
For the Patient: Protocol LUAJNP Other names: Adjuvant Treatment of Non-Small Cell Lung Cancer with Cisplatin and Vinorelbine LU = LUng AJ = AdJuvant NP = Navelbine (vinorelbine), cisplatin ABOUT THIS
Teriflunomide (Aubagio) 14mg once daily tablet
Teriflunomide (Aubagio) 14mg once daily tablet Exceptional healthcare, personally delivered Your Consultant Neurologist has suggested that you may benefit from treatment with Teriflunomide. The decision
Leflunomide Leflunomide
Drug information Leflunomide Leflunomide This leaflet provides information on leflunomide and will answer any questions you have about the treatment. Arthritis Research UK produce and print our booklets
What You Need to Know About LEMTRADA (alemtuzumab) Treatment: A Patient Guide
For Patients What You Need to Know About LEMTRADA (alemtuzumab) Treatment: A Patient Guide Patients: Your doctor or nurse will go over this patient guide with you. It is important to ask any questions
Information for patients receiving short-term hormone treatment and radiotherapy for prostate cancer
Information for patients receiving short-term hormone treatment and radiotherapy for prostate cancer Northern Centre for Cancer Care (NCCC) Freeman Hospital Introduction This leaflet has been written to
Multiple sclerosis disease-modifying drugs second line treatments
Great Ormond Street Hospital for Children NHS Foundation Trust: Information for Families Multiple sclerosis disease-modifying drugs second line treatments The following information should be read in conjunction
Paclitaxel and Carboplatin
PATIENT EDUCATION patienteducation.osumc.edu What is Paclitaxel (pak-li-tax-el) and how does it work? Paclitaxel is a chemotherapy drug known as an anti-microtubule inhibitor. Another name for this drug
MEDICATION GUIDE mitoxantrone (mito-xan-trone) for injection concentrate
MEDICATION GUIDE mitoxantrone (mito-xan-trone) for injection concentrate Read this Medication Guide before you start receiving mitoxantrone and each time you receive mitoxantrone. There may be new information.
The Radiotherapy Department Radiotherapy to the breast Information for patients
Oxford University Hospitals NHS Trust The Radiotherapy Department Radiotherapy to the breast Information for patients page 2 Introduction This leaflet is for people who have had surgery for breast cancer
Answering your questions on Chronic Myeloid Leukaemia (CML)
Answering your questions on Chronic Myeloid Leukaemia (CML) Your guide to understanding CML and Glivec (imatinib) treatment The information in this booklet is designed to help you understand chronic myeloid
Effect of breast cancer treatment
Effect of breast cancer treatment on the bones 1 Effect of breast cancer treatment on the bones This information is from the booklet Managing the late effects of breast cancer treatment. You may find the
Hair loss. During chemotherapy and radiotherapy. Information for patients Weston Park Hospital
Hair loss During chemotherapy and radiotherapy Information for patients Weston Park Hospital page 2 of 12 Cancer treatments such as chemotherapy and radiotherapy can cause total hair loss or thinning.
The main surgical options for treating early stage cervical cancer are:
INFORMATION LEAFLET ON TOTAL LAPAROSCOPIC RADICAL HYSTERECTOMY (TLRH) FOR EARLY STAGE CERVICAL CANCER (TREATING EARLY STAGE CERVICAL CANCER BY RADICAL HYSTERECTOMY THROUGH KEYHOLE SURGERY) Aim of the leaflet
BREAST CANCER TREATMENT
BREAST CANCER TREATMENT Cancer Care Pathways Directorate Tailored Information in Cancer Care (TICC) Sir Anthony Mamo Oncology Centre December 2014 Contents About this booklet 1 Your First Oncology Consultation
TCH: Docetaxel, Carboplatin and Trastuzumab
PATIENT EDUCATION patienteducation.osumc.edu TCH: Docetaxel, Carboplatin and Trastuzumab What is TCH? It is the short name for the drugs used for this chemotherapy treatment. The three drugs you will receive
Multiple Myeloma. This reference summary will help you understand multiple myeloma and its treatment options.
Multiple Myeloma Introduction Multiple myeloma is a type of cancer that affects white blood cells. Each year, thousands of people find out that they have multiple myeloma. This reference summary will help
How To Take A Bone Marrow Transplant
Drug treatments to protect your bones This information is an extract from the booklet, Bone health. You may find the full booklet helpful. We can send you a copy free see page 5. Contents Bisphosphonates
Symptoms of Hodgkin lymphoma
Produced 28.02.2011 Revision due 28.02.2013 Symptoms of Hodgkin lymphoma Lymphoma is a cancer of cells called lymphocytes. These cells are part of our immune system, which helps us to fight off infections.
CANCER TREATMENT: Chemotherapy
CANCER TREATMENT: Chemotherapy Chemotherapy, often called chemo, is the use of drugs to treat a disease. The term chemotherapy is now most often used to describe a type of cancer treatment. Dr. Khuri:
It can be devastating to be diagnosed with a cancer like multiple myeloma. But there are treatments that can help you live longer and feel better.
Patient information from the BMJ Group It can be devastating to be diagnosed with a cancer like multiple myeloma. But there are treatments that can help you live longer and feel better. What is multiple
Epidural Continuous Infusion. Patient information Leaflet
Epidural Continuous Infusion Patient information Leaflet April 2015 Introduction You may already know that epidural s are often used to treat pain during childbirth. This same technique can also used as
Chemoembolization for Patients with Pancreatic Neuroendocrine Tumours
Chemoembolization for Patients with Pancreatic Neuroendocrine Tumours What is this cancer? Pancreatic Endocrine Tumours are also called Pancreatic Neuroendocrine Tumours. This cancer is rare and it starts
For the Patient: Dasatinib Other names: SPRYCEL
For the Patient: Dasatinib Other names: SPRYCEL Dasatinib (da sa' ti nib) is a drug that is used to treat many types of cancer. It is a tablet that you take by mouth. Tell your doctor if you have ever
All about. (bevacizumab) Information for people being treated with Avastin for advanced ovarian cancer
All about (bevacizumab) Information for people being treated with Avastin for advanced ovarian cancer AVASTIN AT A GLANCE Avastin also known as bevacizumab is a medicine used to treat a number of different
Prostate Cancer. There is no known association with an enlarged prostate or benign prostatic hyperplasia (BPH).
Prostate Cancer Definition Prostate cancer is cancer that starts in the prostate gland. The prostate is a small, walnut-sized structure that makes up part of a man's reproductive system. It wraps around
Acute myeloid leukaemia (AML) in children
1 61.02 Acute myeloid leukaemia (AML) in children AML can affect children of any age, and girls and boys are equally affected. Leukaemia Acute myeloid leukaemia (AML) FAB classification of AML Causes of
Breast cancer treatments
Breast cancer treatments i About us Breast Cancer Network Australia (BCNA) is the peak organisation for all people affected by breast cancer in Australia. We provide a range of free resources, including
PATIENT INFORMATION ABOUT ADJUVANT THERAPY AFTER THE WHIPPLE OPERATION FOR ADENOCARCINOMA ( CANCER ) OF THE PANCREAS AND RELATED SITES.
PATIENT INFORMATION ABOUT ADJUVANT THERAPY AFTER THE WHIPPLE OPERATION FOR ADENOCARCINOMA ( CANCER ) OF THE PANCREAS AND RELATED SITES. Radiation Oncology Sidney Kimmel Cancer Center at Johns Hopkins Last
MEDICATION GUIDE POMALYST (POM-uh-list) (pomalidomide) capsules. What is the most important information I should know about POMALYST?
MEDICATION GUIDE POMALYST (POM-uh-list) (pomalidomide) capsules What is the most important information I should know about POMALYST? Before you begin taking POMALYST, you must read and agree to all of
Gemcitabine and Cisplatin
PATIENT EDUCATION patienteducation.osumc.edu What is Gemcitabine (jem-site-a been)? Gemcitabine is a chemotherapy medicine known as an anti-metabolite. Another name for this drug is Gemzar. This drug is
Insertion of a Central Catheter (Hickman/Groshong Catheter)
Insertion of a Central Catheter (Hickman/Groshong Catheter) Patient Information Introduction This booklet has been written to provide information to patients about to have a central catheter inserted in
Headache after an epidural or spinal injection What you need to know. Patient information Leaflet
Headache after an epidural or spinal injection What you need to know Patient information Leaflet April 2015 We have produced this leaflet to give you general information about the headache that may develop
MEDICATION GUIDE. PROCRIT (PRO KRIT) (epoetin alfa)
MEDICATION GUIDE PROCRIT (PROKRIT) (epoetin alfa) Read this Medication Guide: before you start PROCRIT. if you are told by your healthcare provider that there is new information about PROCRIT. if you are
University College Hospital. Contrast agent for radiotherapy CT (computed tomography) scans. Radiotherapy Department Patient information series
University College Hospital Contrast agent for radiotherapy CT (computed tomography) scans Radiotherapy Department Patient information series 11 2 If you need a large print, audio or translated copy of
Kent Oncology Centre Radiotherapy Side Effects and Management: Breast and Chest Wall Information for patients Maidstone Hospital
Kent Oncology Centre Radiotherapy Side Effects and Management: Breast and Chest Wall Information for patients We hope this leaflet will help you understand the side effects that may occur when having external
